TLOG (TetraLogic Pharmaceuticals) Research & Development: $11.91 Mil (TTM As of Sep. 2016)


What is TetraLogic Pharmaceuticals Research & Development?

TetraLogic Pharmaceuticals TLOG Research & Development is $11.91 Mil as of Sep. 2016.

Research & Development is the aggregate amount of research and development expenses during the year. TetraLogic Pharmaceuticals's Research & Development for the three months ended in Sep. 2016 was $-0.04 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2016 was $11.91 Mil.

TetraLogic Pharmaceuticals  (OTCPK:TLOG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

TetraLogic Pharmaceuticals Research & Development Related Terms

TetraLogic Pharmaceuticals Research & Development Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals Research & Development Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
Research & Development
15.25 12.10 9.52 20.29 27.40

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.10 7.15 3.30 1.50 -0.04

TetraLogic Pharmaceuticals Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $11.91 Mil mean?
TetraLogic Pharmaceuticals (TLOG) has a Research & Development of $11.91 Mil as of Sep. 2016. Research and development expense is the total cost for research and development activities. View historical data on TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' Research & Development too high?
TetraLogic Pharmaceuticals' current Research & Development is $11.91 Mil.
How does TetraLogic Pharmaceuticals' Research & Development compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' Research & Development of $11.91 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current Research & Development is $11.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current Research & Development of $11.91 Mil. The current Research & Development is $11.91 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current Research & Development is $11.91 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.